These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35491913)

  • 1. Thirty years of science-society interfaces: What's next?
    Scheufele DA
    Public Underst Sci; 2022 Apr; 31(3):297-304. PubMed ID: 35491913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conceptual framework for understanding the perspectives on the causes of the science-practice gap in ecology and conservation.
    Bertuol-Garcia D; Morsello C; N El-Hani C; Pardini R
    Biol Rev Camb Philos Soc; 2018 May; 93(2):1032-1055. PubMed ID: 29160024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In science communication, why does the idea of a public deficit always return?
    Meyer G
    Public Underst Sci; 2016 May; 25(4):433-46. PubMed ID: 27117771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In science communication, why does the idea of a public deficit always return? How do the shifting information flows in healthcare affect the deficit model of science communication?
    Ko H
    Public Underst Sci; 2016 May; 25(4):427-32. PubMed ID: 27117770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communicating science in social settings.
    Scheufele DA
    Proc Natl Acad Sci U S A; 2013 Aug; 110 Suppl 3(Suppl 3):14040-7. PubMed ID: 23940341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lure of rationality: Why does the deficit model persist in science communication?
    Simis MJ; Madden H; Cacciatore MA; Yeo SK
    Public Underst Sci; 2016 May; 25(4):400-14. PubMed ID: 27117768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding public opinion in debates over biomedical research: looking beyond political partisanship to focus on beliefs about science and society.
    Nisbet M; Markowitz EM
    PLoS One; 2014; 9(2):e88473. PubMed ID: 24558393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies.
    Braun M; Starkbaum J; Dabrock P
    PLoS One; 2015; 10(12):e0145033. PubMed ID: 26660160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science communication as political communication.
    Scheufele DA
    Proc Natl Acad Sci U S A; 2014 Sep; 111 Suppl 4(Suppl 4):13585-92. PubMed ID: 25225389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the role of society and risk in xenotransplantation.
    Sobbrio P; Jorqui M
    Xenotransplantation; 2014; 21(6):523-32. PubMed ID: 25040770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicating CRISPR: Challenges and opportunities in engaging the public.
    Baik ES; Koshy A; Hardy BW
    Prog Mol Biol Transl Sci; 2022; 188(1):171-193. PubMed ID: 35168742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating to and engaging with the public in regulatory science.
    Smith A; Parrino L; Vrbos D; Nicolini G; Bucchi M; Carr M; Chen J; Dendler L; Krishnaswamy K; Lecchini D; Löfstedt R; Patel M; Reisch L; Verloo D; Vos E; Zollo F; Gallani B
    EFSA J; 2019 Jul; 17(Suppl 1):e170717. PubMed ID: 32626454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promises and perils of gene drives: Navigating the communication of complex, post-normal science.
    Brossard D; Belluck P; Gould F; Wirz CD
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7692-7697. PubMed ID: 30642954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of scientists with the public and policymakers to promote alternative methods.
    Von Aulock S; Busquet F; Locke P; Herrmann K; Hartung T
    ALTEX; 2022; 39(4):543-559. PubMed ID: 36317779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring risk/benefit perceptions of emerging technologies and their potential impact on communication of public opinion toward science.
    Binder AR; Cacciatore MA; Scheufele DA; Shaw BR; Corley EA
    Public Underst Sci; 2012 Oct; 21(7):830-47. PubMed ID: 23832561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving Forward after Sendai: How Countries Want to Use Science, Evidence and Technology for Disaster Risk Reduction.
    Calkins J
    PLoS Curr; 2015 May; 7():. PubMed ID: 26463730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes to biotechnology: estimating the opinions of a better-informed public.
    Sturgis P; Cooper H; Fife-Schaw C
    New Genet Soc; 2005 Apr; 24(1):31-56. PubMed ID: 16552916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science in the Public Eye: Leveraging Partnerships-An Introduction.
    Merson M; Allen LC; Hristov NI
    Integr Comp Biol; 2018 Jul; 58(1):52-57. PubMed ID: 29939248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.